Reporting Manager
RA Capital Management, L.P.
Symbol
DRUG
Shares outstanding
7,118,172 shares
Disclosed Ownership
206,427 shares
Ownership
2.9%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:51:22 UTC
Date of event
31 Mar 2025

Sponsored

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 2.9% ownership in Bright Minds Biosciences Inc. Common Shares (DRUG) on 31 Mar 2025."

Quick Takeaways

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for Bright Minds Biosciences Inc. Common Shares (DRUG).
  • Disclosed ownership: 2.9%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 16:51.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 2.9% 206,427 0 206,427 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 2.9% 206,427 0 206,427 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 2.9% 206,427 0 206,427 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 2.9% 206,427 0 206,427 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager